Adenomyosis and Obstetrical Outcome: a Narrative Mini-Review of the Latest Evidence

In: Current Obstetrics and Gynecology Reports · 2022 · vol. 13(4) , pp. 289–300 · doi:10.1007/s13669-021-00316-1 · W4226479847
article OA: closed CC0 ⤵ 2 in-corpus citations
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-07-09 ⓘ

Adenomyosis is associated with preterm delivery, lower pregnancy rates after ART, higher rates of SGA/LBW infants, cesarean delivery, and hypertensive disorder of pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

This narrative mini-review critically evaluated recent evidence (PubMed, Google Scholar, and Cochrane searches from January 2016 to March 2021) from nine observational studies on obstetric outcomes in women with adenomyosis. Across included studies, adenomyosis was consistently associated with preterm delivery, and available data linked adenomyosis with lower pregnancy rates after assisted reproductive techniques (ART) and higher rates of small-for-gestational-age/low-birth-weight infants, cesarean delivery, and hypertensive disorder of pregnancy. The review explicitly notes major limitations across eligible studies, including a predominance of ART pregnancies (with ART itself associated with adverse outcomes), incomplete reporting on endometriosis status, nonhomogeneous diagnostic criteria, lack of adenomyosis severity characterization, and variable timing of diagnosis relative to pregnancy. This paper does not explicitly focus on adenomyosis as a standalone clinical condition; it is centrally about endometriosis-related adenomyosis risk in the broader context of pelvic pathologies, and it specifically addresses adenomyosis obstetrical outcomes, which are relevant to adenomyosis and also to endometriosis because it notes missing endometriosis information when interpreting the evidence.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 10,577 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Purpose of Review To critically evaluate the most recent evidence on obstetric outcomes in women with adenomyosis. Recent Findings There is growing evidence suggesting an increased risk of obstetrical complications in women with adenomyosis. Summary An electronic search was conducted among the databases of PubMed, Google Scholar, and Cochrane review from January 2016 to March 2021. Nine observational studies fulfilled the inclusion criteria. Limitations of eligible studies include the presence of a majority of pregnancies achieved by ART, despite ART pregnancies being reported to be associated per se with a higher risk of adverse obstetric outcome; lack of information regarding the presence or absence of endometriosis; nonhomogeneous diagnostic criteria for adenomyosis; lack of the description of the severity of adenomyosis; and different timing of the diagnosis either before or during pregnancy. All studies reported that adenomyosis is associated with preterm delivery. Moreover, available data suggest that adenomyosis is associated with lower pregnancy rates after assisted reproductive techniques (ART) and higher rates of small-for-gestational-age (SGA)/low–birth weight (LBW) infants, cesarean delivery, and hypertensive disorder of pregnancy (HDP). Further studies on naturally conceived pregnancies, accurately designed in order to consider potential confounding factors, are needed in order to estimate the actual role of adenomyosis on fertility and obstetric and neonatal outcomes. Until more accurate data are available, it seems wise to foresee, when managing pregnant women with adenomyosis, the possible need for additional obstetric and intra-partum care. Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G, Taniguchi F. The Impact of Adenomyosis on Women’s Fertility. Obstet Gynecol Surv. 2016;71:557–68. https://doi.org/10.1097/OGX.0000000000000346. •• Nirgianakis K, Kalaitzopoulos DR, Schwartz ASK, Spaanderman M, Kramer BW, Mueller MD, et al. Pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online. 2021;42:185–206. https://doi.org/10.1016/j.rbmo.2020.09.023. Epub 2020 Oct 4. Findings from this study suggest that adenomyosis is associated with a significantly lower clinical pregnancy rate and higher miscarriage rate after ART, especially when a short GnRH agonist or antagonist protocol is administered for ovarian stimulation. Van den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46:284–98. https://doi.org/10.1002/uog.14806. Epub 2015 Aug 10. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109:389–97. https://doi.org/10.1016/j.fertnstert.2018.01.024. • Hashimoto A, Iriyama T, Sayama S, Nakayama T, Komatsu A, Miyauchi A, et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. J Matern Fetal Neonatal Med. 2018;31:364–9. https://doi.org/10.1080/14767058.2017.1285895. Epub 2017 Feb 9. In this matched, case-control study, they found that patients who had adenomyosis were more likely associated with spontaneous second trimester miscarriage, preeclampsia, placental malposition, and preterm delivery, and to delivery of a SGA infant. Scala C, Leone Roberti Maggiore U, Racca A, Barra F, Vellone VG, Venturini PL, et al. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis. Ultrasound Obstet Gynecol. 2018;52:666–671. https://doi.org/10.1002/uog.18989. Sharma S, Bathwal S, Agarwal N, Chattopadhyay R, Saha I, Chakravarty B. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reprod Biomed Online. 2019;38:13–21. https://doi.org/10.1016/j.rbmo.2018.09.014. Epub 2018 Oct 26. Shin YJ, Kwak DW, Chung JH, Kim MY, Lee SW, Han YJ. The risk of preterm births among pregnant women with adenomyosis. J Ultrasound Med. 2018;37:1937–43. https://doi.org/10.1002/jum.14540. Epub 2018 Jan 24. Shinohara S, Okuda Y, Hirata S, Suzuki K. Adenomyosis as a potential risk factor for adverse pregnancy outcomes: a multicenter case-control study. Tohoku J Exp Med. 2020;251:231–9. https://doi.org/10.1620/tjem.251.231. Yamaguchi A, Kyozuka H, Fujimori K, Hosoya M, Yasumura S, Yokoyama T, et al. Japan Environment and Children’s Study Group. Risk of preterm birth, low birthweight and small-for-gestational-age infants in pregnancies with adenomyosis: a cohort study of the Japan Environment and Children’s Study. Acta Obstet Gynecol Scand. 2019 Mar;98:359–364. https://doi.org/10.1111/aogs.13498. Epub 2018 Dec 2. Neal S, Morin S, Werner M, Gueye NA, Pirtea P, Patounakis G, et al. Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study. Ultrasound Obstet Gynecol. 2020;56:611–7. https://doi.org/10.1002/uog.22065. Mavrelos D, Holland TK, O’Donovan O, Khalil M, Ploumpidis G, Jurkovic D, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod Biomed Online. 2017;35:549–54. https://doi.org/10.1016/j.rbmo.2017.06.026. Epub 2017 Jul 29. Hou X, Xing J, Shan H, Mei J, Sun Y, Yan G, et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online. 2020;41:845–53. https://doi.org/10.1016/j.rbmo.2020.07.027 (Epub 2020 Aug 1). Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012 Sep-Oct;18:485–503. doi: https://doi.org/10.1093/humupd/dms018. Epub 2012 May 19. Qin JB, Sheng XQ, Wu D, Gao SY, You YP, Yang TB, et al. Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017;295:285–301. https://doi.org/10.1007/s00404-016-4250-3 (Epub 2016 Nov 28). Juang CM, Chou P, Yen MS, Twu NF, Horng HC, Hsu WL. Adenomyosis and risk of preterm delivery. BJOG. 2007;114:165–9. https://doi.org/10.1111/j.1471-0528.2006.01186.x. Epub 2006 Dec 4. Brosens I, Pijnenborg R, Benagiano G. Defective myometrial spiral artery remodeling as a cause of major obstetrical syndromes in endometriosis and adenomyosis. Placenta. 2013;34:100–5. Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum Reprod Update. 2016 Jan-Feb;22:104–15. doi: https://doi.org/10.1093/humupd/dmv044. Epub 2015 Sep 22. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril. 2017;108:483-490.e3. https://doi.org/10.1016/j.fertnstert.2017.06.025. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29:964–77. https://doi.org/10.1093/humrep/deu041. Epub 2014 Mar 12. Mochimaru A, Aoki S, Oba MS, Kurasawa K, Takahashi T, Hirahara F. Adverse pregnancy outcomes associated with adenomyosis with uterine enlargement. J Obstet Gynaecol Res. 2015;41:529–33. https://doi.org/10.1111/jog.12604. Epub 2014 Nov 3. •• Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;11(25):592–632. https://doi.org/10.1093/humupd/dmz012. Findings from this study suggest that adenomyosis and endometriosis have a negative impact on oocyte yield and number of mature oocytes and they increase the risk of miscarriage, preterm birth, cesarean section delivery, and neonatal unit admission following delivery. Vercellini P, Parazzini F, Pietropaolo G, Cipriani S, Frattaruolo MP, Fedele L. Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis: a retrospective cohort study. BJOG. 2012;119:1538–43. https://doi.org/10.1111/j.1471-0528.2012.03466.x. Epub 2012 Aug 20. Exacoustos C, Lauriola I, Lazzeri L, De Felice G, Zupi E. Complications during pregnancy and delivery in women with untreated rectovaginal deep infiltrating endometriosis. Fertil Steril. 2016;106:1129-1135.e1. Vercellini P, Frattaruolo MP, Barbara G, Buggio L, Somigliana E. The ominous association between severe endometriosis, in vitro fertilisation, and placenta previa: raising awareness, limiting risks, informing women. BJOG. 2018;125:12–5. https://doi.org/10.1111/1471-0528.14789. Epub 2017 Jul 26. Author information Authors and Affiliations Contributions NB and PV were responsible for conception and design of the study and for critical revision of the article for intellectual content. Acquisition of data was performed by AD, FF, and ML. Analysis and interpretation of data was accomplished by NB and PV. All the authors approved the final version of the manuscript. Corresponding author Ethics declarations Conflict of Interest Nicola Berlanda, Agnese Donati, Francesco Fedele, Massimo Lepri, and Paolo Vercellini declare that they have no conflict of interest. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article is part of the Topical Collection on Uterine Fibroids and Endometrial Lesions Rights and permissions About this article Cite this article Berlanda, N., Donati, A., Fedele, F. et al. Adenomyosis and Obstetrical Outcome: a Narrative Mini-Review of the Latest Evidence. Curr Obstet Gynecol Rep 13, 289–300 (2024). https://doi.org/10.1007/s13669-021-00316-1 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s13669-021-00316-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-25T06:33:09.130943+00:00
License: CC0 · commercial use OK